0001209191-19-003420.txt : 20190111
0001209191-19-003420.hdr.sgml : 20190111
20190111162317
ACCESSION NUMBER: 0001209191-19-003420
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190109
FILED AS OF DATE: 20190111
DATE AS OF CHANGE: 20190111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEUNG GABRIEL
CENTRAL INDEX KEY: 0001236183
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 19522536
MAIL ADDRESS:
STREET 1: C/O PERNIX THERAPEUTICS HOLDINGS, INC.
STREET 2: 10 NORTH PARK PLACE, SUITE 201
CITY: MORRISTOWN
STATE: NJ
ZIP: 07960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-09
0
0001645113
NovoCure Ltd
NVCR
0001236183
LEUNG GABRIEL
C/O NOVOCURE INC.
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
1
0
0
0
Ordinary Shares
2019-01-09
4
M
0
20000
3.44
A
80000
D
Ordinary Shares
2019-01-09
4
S
0
13274
40.00
D
66726
D
Ordinary Shares
2019-01-09
4
S
0
6726
40.01
D
60000
D
Options to Buy Ordinary Shares
3.44
2019-01-09
4
M
0
20000
0.00
A
2021-09-14
Ordinary Shares
20000
149743
D
These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung.
These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung.
Fully vested as of the date hereof.
/s/ Kimberly Burke, Attorney in fact for Kinyip Gabriel Leung
2019-01-11